References
Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201. doi:10.1038/nrc2073
Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19:623–629. doi:10.1093/annonc/mdm500
Tannock IF, Ahles TA, Ganz PA, van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22:2233–2239. doi:10.1200/JCO.2004.08.094
Quesnel C, Savard J, Ivers H (2008) Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat. doi:10.1007/s10549-008-0114-2
Hermelink K, Untch M, Lux MP et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905–1913. doi:10.1002/cncr.22610
Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98:1742–1745
Schagen SB, Vardy J (2007) Cognitive dysfunction in people with cancer. Lancet Oncol 8:852–853. doi:10.1016/S1470-2045(07)70287-5
Jenkins V, Shilling V, Deutsch G et al (2006) A 3 year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828–834. doi:10.1038/sj.bjc.6603029
Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurrence. Oxford University Press, New York
Chelune CJ, Naugle RI, Lueders H, Sedlak J, Awad IIA (1993) Individual change after epilepsy surgery: practice effects and base-rate information. Neuropsychology 7:41–52. doi:10.1037/0894-4105.7.1.41
Heaton RK, Temkin N, Dikmen S et al (2001) Detecting change: a comparison of three neuropsychological methods, using normal and clinical samples. Arch Clin Neuropsychol 16:75–91. doi:10.1016/S0887-6177(99)00062-1
Sherwin BB (2003) Estrogen and cognitive functioning in women. Endocr Rev 24:133–151. doi:10.1210/er.2001-0016
Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S (2004) Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 13:61–66. doi:10.1002/pon.709
Castellon SA, Ganz PA, Bower JE, Petersen LA, Abraham L, Greendale GA (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955–969. doi:10.1080/13803390490510905
Silverman DH, Dy CJ, Castellon SA et al (2007) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat 103:303–311. doi:10.1007/s10549-006-9380-z
Saykin AJ, Wishart HA, Rabin LA et al (2006) Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 67:834–842. doi:10.1212/01.wnl.0000234032.77541.a2
Sherwin BB, Henry JF (2008) Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol 29:88–113
Ferguson RJ, Ahles TA, Saykin AJ et al (2007) Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 16:772–777. doi:10.1002/pon.1133
Acknowledgment
Supported in part by the Breast Cancer Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an invited commentary to doi:10.1007/s10549-005-9114-7.
Rights and permissions
About this article
Cite this article
Castellon, S., Ganz, P.A. Neuropsychological studies in breast cancer: in search of chemobrain. Breast Cancer Res Treat 116, 125–127 (2009). https://doi.org/10.1007/s10549-008-0211-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0211-2